Skip to main content

Table 1 Population characteristics at baseline

From: Atrial fibrillation in aortic stenosis - echocardiographic assessment and prognostic importance

  CONTROLS CASES P-value
Aortic stenosis & sinus rhythm Aortic stenosis & atrial fibrillation
Age , years 78 (73–84) 78 (73–84) 0.96
Male gender, n (%) 70 (68) 70 (68) 1.00
Body Mass Index, kg/m2 25.7 (22.3–28.1) 25.5 (22.3–27.5) 0.65
Body Surface Area, m2 1.88 (1.76–2.06) 1.89 (1.75–2.06) 0.90
Heart rate (bpm) 68 (63–77) 81 (73–96) <0.001
Cardiovascular risk factors and co-morbidities
Hypertension, n (%) 57 (57) 55 (55) 0.78
Smoking (previous or current), n (%) 57 (64) 65 (72) 0.24
Peripheral vascular disease, n (%) 5 (5) 13 (16) 0.02
Diabetes (Type I or II), n (%) 22 (21) 25 (24) 0.62
Hypercholesterolemia, n (%) 47 (49) 46 (46) 0.63
Stroke, n (%) 15 (15) 14 (15) 0.94
Ischaemic heart disease, n (%) 27 (26) 34 (33) 0.29
Familiar disposition, n (%) 14 (18) 16 (22) 0.49
Chronic lung disease, n (%) 22 (21) 17 (17) 0.38
Medication
β-blockers, n (%) 37 (41) 58 (58) 0.02
Calcium-antagonists, n (%) 21 (23) 22 (22) 0.83
ACE-inhibitors and/or Angiotensin-II-receptor-antagonists, n (%) 42 (47) 38 (38) 0.23
Diuretics (any kind), n (%) 46 (51) 65 (65) 0.05
Loop-diuretics, n (%) 19 (21) 51 (51) <0.001
Thiazides, n (%) 27 (30) 15 (15) 0.013
Potassium-sparing diuretics, n (%) 6 (7) 9 (9) 0.55
Insuline, n (%) 11 (12) 3 (3) 0.02
Oral antidiabetics, n (%) 10 (11) 14 (14) 0.55
Statins, n (%) 51 (57) 48 (48) 0.23
Aspirin, n (%) 57 (63) 50 (50) 0.06
Inhaled Medications (glucocorticoids/anticholinergics/β2-agonists), n (%) 9 (10) 11 (11) 0.82
Warfarin, n (%) 5 (6) 59 (59) <0.001
Digoxin, n (%) 0   45 (45) <0.001
Amiodarone, n (%) 0   2 (2) 0.18
Operative risk calculations
Additive EuroSCORE 8 (7–10) 9 (7–10) 0.05
Additive EuroSCORE without LV dysfunction 7 (6–9) 7 (6–9) 0.39
Symptoms
Symptoms (angina pectoris, dyspnea, dizziness, syncope), n (%) 75 (77) 87 (86) 0.08
Angina pectoris, n (%) 43 (43) 28 (28) 0.02
Dyspnea, n (%) 59 (63) 80 (80) 0.008
Dizziness, n (%) 12 (13) 17 (17) 0.41
Syncope, n (%) 5 (5) 9 (9) 0.31